Dexfenfluramine & Weight Loss
Dexfenfluramine Effects
The long-term effects of dexfenfluramine on the morbidity and mortality associated with obesity have not been established.
Dexfenfluramine—An anorectic drug formerly marketed under the brand name Redux.
Etiology—The cause of a disease or medical condition.
Fenluramine—An anorectic drug formerly marketed under the brand name Pondimin.
FDA ANNOUNCES WITHDRAWAL OF FENFLURAMINE AND DEXFENFLURAMINE
The Food and Drug Administration, acting on new evidence about significant side-effects associated with fenfluramine and dexfenfluramine, ...
Two appetite-suppressant medications, fenfluramine and dexfenfluramine, were withdrawn from the market in 1997.
Meridia (Sibutramine) diet pills act on both the serotonin and catecholamine systems, but unlike fenfluramine and dexfenfluramine, sibutramine does not cause release of serotonin from cells.
It should be noted that the vast majority of cases of PPH have occurred in patients who were taking fenfluramine or dexfenfluramine, either alone or in combination.
Effect of dietary manipulation on substrate flux and energy balance in obese women taking the appetite suppressant dexfenfluramine. Am J Clin Nutr 68:1012-1021. Popp-Snijders C, Schouten JA, Heine RJ, van der Meer J, van der Veen EA. 1987.
 See also: Weight loss, Obesity, Fenfluramine, Eating, Health
  
|
RSS
